Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/254908COMPARTIR / EXPORTAR:
 SHARE
 CORE
BASE
|
|
| Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
| Título: | EGFRAP encodes a new negative regulator of the EGFR acting in both normal and oncogenic EGFR/Ras-driven tissue morphogenesis |
Autor: | Soler Beatty, Jennifer CSIC ORCID; Molnar, Cristina CSIC ORCID; Luque, Carlos M. CSIC ORCID; Celis, José F. de CSIC ORCID; Martín-Bermudo, María D. CSIC ORCID | Fecha de publicación: | 19-ago-2021 | Editor: | Public Library of Science | Citación: | PLoS Genetics 17(8): e1009738 (2021) | Resumen: | Activation of Ras signaling occurs in ~30% of human cancers. However, activated Ras alone is insufficient to produce malignancy. Thus, it is imperative to identify those genes cooperating with activated Ras in driving tumoral growth. In this work, we have identified a novel EGFR inhibitor, which we have named EGFRAP, for EGFR adaptor protein. Elimination of EGFRAP potentiates activated Ras-induced overgrowth in the Drosophila wing imaginal disc. We show that EGFRAP interacts physically with the phosphorylated form of EGFR via its SH2 domain. EGFRAP is expressed at high levels in regions of maximal EGFR/Ras pathway activity, such as at the presumptive wing margin. In addition, EGFRAP expression is up-regulated in conditions of oncogenic EGFR/Ras activation. Normal and oncogenic EGFR/Ras-mediated upregulation of EGRAP levels depend on the Notch pathway. We also find that elimination of EGFRAP does not affect overall organogenesis or viability. However, simultaneous downregulation of EGFRAP and its ortholog PVRAP results in defects associated with increased EGFR function. Based on these results, we propose that EGFRAP is a new negative regulator of the EGFR/Ras pathway, which, while being required redundantly for normal morphogenesis, behaves as an important modulator of EGFR/Ras-driven tissue hyperplasia. We suggest that the ability of EGFRAP to functionally inhibit the EGFR pathway in oncogenic cells results from the activation of a feedback loop leading to increase EGFRAP expression. This could act as a surveillance mechanism to prevent excessive EGFR activity and uncontrolled cell growth. | Descripción: | © 2021 Soler Beatty et al. | Versión del editor: | http://dx.doi.org/10.1371/journal.pgen.1009738 | URI: | http://hdl.handle.net/10261/254908 | DOI: | 10.1371/journal.pgen.1009738 | ISSN: | 1553-7390 | E-ISSN: | 1553-7404 |
| Aparece en las colecciones: | (CABD) Artículos (CBM) Artículos |
Ficheros en este ítem:
| Fichero | Descripción | Tamaño | Formato | |
|---|---|---|---|---|
| Egfrap_Soler_PV_Art2021.pdf | 6,95 MB | Adobe PDF |  Visualizar/Abrir |
CORE Recommender
SCOPUSTM
Citations
5
checked on 20-abr-2024
WEB OF SCIENCETM
Citations
5
checked on 25-feb-2024
Page view(s)
34
checked on 26-abr-2024
Download(s)
40
checked on 26-abr-2024
Google ScholarTM
Check
Altmetric
Altmetric
Este item está licenciado bajo una Licencia Creative Commons
